Genetic variation among orthologous proteins can cause cryptic phenotypic properties that only manifest in changing environments. Such variation may also impact the evolutionary potential of proteins, but the molecular basis for this remains unclear. Here we perform comparative directed evolution in which four orthologous metallo-βlactamases were evolved toward a new function. We found that genetic variation between these enzymes resulted in distinct evolutionary outcomes. The ortholog with the lower initial activity reached a 20-fold higher fitness plateau exclusively via increasing catalytic activity. By contrast, the ortholog with the highest initial activity evolved to a less-optimal and phenotypically distinct outcome through changes in expression, oligomerization and activity. We show that the cryptic molecular properties and conformational variation of residues in the initial genotypes cause epistasis, thereby constraining evolutionary outcomes. Our work highlights that understanding the molecular details relating genetic variation to protein functions is essential to predicting the evolution of proteins.
Introduction
Genetic diversity across orthologous proteins is thought to be predominantly neutral with respect to their native, physiological function, but can cause "cryptic genetic variation", i.e., variation in other non-physiological phenotypic properties [1] [2] [3] . Cryptic genetic variation has been shown to play an important role in evolution, because genetically diverse populations are more likely contain genotypes with a "pre-adapted" phenotype, e.g., a latent promiscuous function, that confer an immediate selective advantage when the environment changes and a new selection pressure emerges [4] [5] [6] [7] [8] . Beyond these examples, however, we have little understanding of how genetic variation affects longterm adaptive evolutionary potential or the "evolvability" of proteins 9 . Many biological traits, in particular promiscuous proteins functions, often evolve by accumulating multiple adaptive mutations before reaching a fitness plateau or peak. Thus, the degree to which the trait can improve and the level of peak fitness that it can reach ultimately determines the evolutionary potential and outcomes 10 . Recent studies have shown that, due to intramolecular epistasis [11] [12] [13] the phenotypic effects of the same mutations introduced into orthologous proteins can exhibit variable phenotypic effects 14, 15 , this is true even if they are introduced into a genotype that differs by only a few other mutations 16, 17 . However, having examined only a small subset of mutations, the degree to which genetic starting points determines long-term evolutionary outcomes given the same selection remains unclear 18, 19 . Moreover, we have very little understanding of the molecular mechanisms that underlie the relationship between genetic variation and evolvability. It has been suggested that protein fold [20] [21] [22] and protein stability 23-25 can determine evolvability, but these alone cannot explain the prevalence of epistasis and the enormous variation we observe in the evolvability of different genotypes.
Metallo-β-lactamases (MBLs) encompass a genetically diverse enzyme family that confer β-lactam antibiotic resistance to bacteria (Fig. 1a,b) 26, 27 . Our previous work demonstrated that most MBLs exhibit phosphonate monoester hydrolase (PMH) activity (k cat /K M ) in the range of 0.1 to 10 M -1 s -127,28 . β-lactamase and PMH hydrolysis differs by scissile bond (C-N vs. P-O) and transition state geometry (tetrahedral vs. trigonal bipyramidal), making the PMH activity a catalytically distinct promiscuous activity for these enzymes. Here, we perform an empirical test of enzyme evolvability by performing was not employed in the last two rounds (R9 and R10), yet no variant with further improved fitness was isolated ( Fig. 1d) . Besides the similar trend of the trajectory, there were substantial differences in their evolutionary outcomes; NDM1 was initially 4-fold less-fit than VIM2, but its fitness was 28-fold higher by the end of the evolutionary experiment. The NDM1 trajectory improved by 3600-fold, whereas the VIM2 trajectory improved by only 35-fold, resulting in a 100-fold difference in their relative evolvability with respect to PMH fitness. Given that the two WT enzymes were almost identical in terms of their physicochemical properties, protein solubility, stability and structure ( Fig.   1a,b) , the variation in the evolutionary potential that separates these orthologous sequences is substantial.
Genotypic solutions vary across the evolutionary trajectories.
Overall, NDM1 and VIM2 accumulated 13 and 15 mutations respectively. Interestingly, the mutations occurred along each trajectory were entirely distinct ( Fig. 1e, and Supplementary Table S2 ). Only two mutations occurred at the same position (154 and 223), and these were mutated to different amino acids. For example, the mutations in the early rounds of evolution, which conferred the largest fitness improvements, were W93G, N116T, and K211R in the NDM1 trajectory, and V72A, and F67L for VIM2. In NDM1, most mutations are scattered relatively evenly around the active site; only one mutation (W93G) is located below loop 3, and several are located in and around loop 10 and other parts of the active site. By contrast, in VIM2, six mutations are tightly clustered within or next to loop 3. These results demonstrate that the distinct phenotypic outcomes for the two enzymes result from distinct mutational responses.
Repeatability and determinism of evolutionary adaptation
An important question that arises from the observation that the two enzymes followed different mutational paths is whether this occurred because of differences in their innate molecular property for evolvability, or if it was due to random chance from experimental variation. To address this, we pursued several lines of evidence that suggest the observed trajectories are largely deterministic (Fig. 2) . First, we generated and screened two additional libraries from each wild-type enzyme, which repeatedly identified the same mutations that are observed in early rounds of the original directed evolution (W93G in R1 for NDM1 and V72A and F67L in R1 and 2, respectively, for VIM2, Fig. 2a ). Second, we assessed the epistatic effects of the mutations by introducing the mutations that occurred between R2-R4 into the corresponding wild-type genetic background, and found that the positive effect of later mutations in NDM1 confer a selective advantage only after the fixation of the initial mutations along that trajectory ( Fig. 2b) . Third, we introduced the initial mutation from each trajectory (W93G for NDM1 and V72A for VIM2) into the counterpart enzyme and assayed its effect on fitness, which revealed that each trajectory's adaptive mutations are incompatible with the other's. W93G, which increased fitness for NDM1 by 25-fold, caused a 6-fold fitness decrease for VIM2-WT, thus explaining why VIM2 did not acquire this mutation during its evolution ( Fig. 2c) . Introducing other hydrophobic residues (A, V, L and F) at position Trp93 in VIM2 had similar negative effects ( Fig. 2d) . Similarly, V72A, which improved the fitness of VIM2 by around 2-fold, was largely neutral for NDM1 ( Supplementary Fig. 2 , and Supplementary Table 4 ).
Taken together, this evidence suggests that intramolecular epistasis results in each genotype only having a limited and unique set of mutations available for adaptation to the PMH activity, which results in mostly repeatable and deterministic evolutionary trajectories.
Distinct molecular changes underlie the two evolutionary trajectories
The conventional paradigm of protein evolution is dominated by the idea that higher protein stability, or greater soluble expression, promotes protein evolvability, buffering the destabilizing effect of function-altering mutations, allowing a greater number of adaptive mutations to accumulate 23-25 . This model, however, fails to predict the difference in evolvability between NDM1 and VIM2, because their relative stability and solubility are similar ( Fig. 1b) . In order to elucidate the precise molecular changes that enabled each trajectory's optimization, we measured a range of molecular properties, including catalytic efficiency (k cat /K M ), solubility, melting temperature (T m ), and oligomeric assembly, over the course of their evolution. The molecular changes that underlie their respective fitness improvements differed substantially ( Figs. 3, Supplementary Fig. 3 and Supplementary Tables 5-7 ). In NDM1, k cat /K M improved by 20,000-fold from 0.32 to 5,900 M -1 s -1 by R10 ( Figs. 3a-b) . The significant improvement, however, was offset by a loss of protein solubility, which mostly occurred in R1, where k cat /K M increased 300fold, but solubility decreased from 43% to 25% ( Figs. 3c-d) . The level of solubility never recovered, while k cat /K M gradually increased until it reached the plateau observed in R7.
By contrast, the k cat /K M of VIM2 stagnated at only a 30-fold increase up to round 6, with the subsequent fitness improvements being due to improvement in solubility from 40% to 70% ( Fig. 3) . Changes in solubility are only weakly correlated to changes in T m , indicating that other factors such as kinetic stability or protein folding affect the level of soluble protein expression more than thermostability ( Supplementary Fig. 3 ). NDM1 retains the same monomeric quaternary structure along its trajectory to NDM1-R10. The monomeric VIM2-WT, however, evolved to exist in an equilibrium between monomer and dimer by VIM2-R10 ( Supplementary Fig. 4a ). We isolated monomeric and dimeric states using size-exclusion chromatography, and determined their respective kinetic parameters. The dimer state is less active than the monomer state for PMH activity, indicating that the dimer formation may be associated with increased in overall solubility along the VIM2 trajectory ( Supplementary Fig. 4b ).
Altogether, our results confirm that differences in protein stability cannot explain the differences in evolvability between the two enzymes. VIM2 variants consistently exhibit higher stability and solubility throughout the trajectory, yet the improvements in k cat /K M and fitness are far lower than that of NDM1. Moreover, the distinct phenotypic solutions further highlight the qualitatively different evolutionary processes that led to each trajectory's fitness plateau. Interestingly, the genetic differences in the evolutionary end points can create additional cryptic variation that becomes apparent when the environment is changed: when the enzymes are expressed at 37°C (rather that the 30°C at which they evolved PMH activity) NDM1 variants are significantly less fit because of their lower soluble expression, whereas VIM2 variants maintain similar fitness levels even at the higher temperature ( Supplementary Fig. 5 ).
Structural adaptation between the evolutionary trajectories
Having established that protein stability does not constrain the evolvability of the enzymes, we sought a molecular explanation by solving the crystal structures of the R10 variants for both trajectories, allowing to us compare them with the previously published wild-type structures ( Fig. 4 and Supplementary Table 8 ) 31, 32 . For NDM1-R10 we obtained crystal structures of the apo-enzyme and a complex with the phenylphosphonate product bound in the active site after in crystallo substrate turnover. Additionally, we conducted molecular dynamics (MD) simulations in complex with the PMH substrate (pnitrophenyl phenylphosphonate, PPP). We identified three main structural adaptations from NDM1-WT that underlies the 20,000-fold improvement in PMH activity. First, W93G removes the steric hindrance between the side chain of Trp93 and the substrate, and generates a complementary pocket for the phenyl group below loop 3 (Figs. 4b and S6). Second, there is a displacement of loop 3 (Trp93 is located near the base of this loop) inward by ~6 Å, which allows for improved π-π stacking interactions between Phe70 and the p-nitrophenol-leaving group ( Figs. 4c and Supplementary Fig. 6 ). Third, loop 10 is repositioned via reorganization of the local hydrogen bond network (largely by K211R and G222D), allowing it to interact with the leaving group of the substrate (Fig.   4c ). For VIM2, we were only able to crystallize the dimer fraction of VIM2-R10. This dimer reveals an unprecedented structural rearrangement: a full half of the structure is symmetrically domain-swapped between two subunits ( Figs. 4d and Supplementary Fig.   6 ). Besides the domain swapping, the major structural arrangement between VIM2-WT and VIM2-R10 involves the reorganization loop 3, as loop 3 is disordered in VIM2-R10, which is caused by six mutations that occurred within and next to loop3 ( Figs. 1e and 4d) .
Four of these six these loop 3 mutations were accumulated by R5, and thus we speculate that these mutations and the loop rearrangement was the major cause of 30-fold increase in PMH activity in VIM2. Taken together, the results further emphasize that the two starting enzymes responded to the same selection pressure by substantially different molecular changes.
Molecular basis for the mutational incompatibility of the key mutation W93G.
Finally, we investigated the molecular basis for a key mutation that differentiates the two trajectories: W93G. This mutation caused a 100-fold increase in the catalytic activity of NDM1, but when introduced into VIM2, it reduces PMH activity by 10-fold ( Supplementary Fig. 2) . We performed and compared MD simulations of NDM1-WT, VIM2-WT and models of NDM1-W93G, and VIM2-W93G in the presence of the PMH substrate ( Figs. 5, Supplementary Fig. 8 and Supplementary Tables 9-10 ). NDM1-W93G showed similar structural adaptations as observed in NDM1-R10 (described above); W93G eliminates the steric hindrance with the substrate, and allows loop 3 to shift inward to promote complementary interactions with the substrate, but without the rearrangement of loop 10, which presumably occurs later in that evolutionary trajectory.
By contrast, in VIM2-WT, Trp93 adopts a different orientation, avoiding steric hindrance and instead promotes complementary interactions with the phenyl ring of the substrate.
Consequently, W93G in VIM2 removes beneficial substrate-enzyme interactions, thus causing a deleterious effect on PMH activity. Similarly, unlike in NDM1, in VIM2-W93G, loop 3 does not form complementary interactions with the substrate, which is consistent with the observation that loop 3 is extensively mutated and reorganized by other mutations later in the VIM2 trajectory. By examining these crystal structures, we found that the "second-shell" residues of Trp93 cause different orientations of the indole sidechain. In NDM1, Leu65, Gln123 and Asp124 constrain Trp93 to point into the active site (Fig 5d) . In VIM2, however, the second shell residues (Gln65, Asp123, and Asp124) differ, resulting in Trp93 being stabilized in an alternative conformation ( Fig. 5e ). Thus, remote and seemingly neutral sequence variation between the enzymes has a substantial impact on the mutagenesis of a key active site residue.
We expanded our mutational analysis of W93G and V72A (the first mutation in the VIM2 trajectory) to four other orthologous enzymes (EBL1, FIM1, VIM1, VIM7) and found that their effects for both PMH and β-lactamase activities consistently vary significantly, even between orthologs with high sequence identity ( Supplementary Fig.   2 ). For example, in VIM7, which is 80% identical to VIM2, W93G caused a 3-fold increase in activity, despite the same mutation causing a 10-fold decrease in VIM2.
Taken together, cryptic and subtle differences in sequence and structure, can influence the conformation of a key active site residue, causing an approximately 3000-fold difference in the phenotypic effect of a mutation, and thereby leading to distinct evolutionary outcomes among orthologous enzymes.
Discussion
The great diversity of protein functions, and many contemporary examples of proteins that have promptly adapted to changing environments suggest a remarkable degree of evolvability for biological molecules 33,34 .These successful cases of adaptation, however, may also obscure a wealth of cases where proteins failed, or were limited, in their evolution of a new function. Our observations highlight that not all enzymes are equally evolvable, and that seemingly innocuous genetic variation can result in significant consequences for a protein's ability to evolve a new function. Thus, this work elaborates on the known role of cryptic genetic variation in generating diverse, hidden "pre-adapted"
properties [5] [6] [7] , extending this view to encompass the adaptive evolutionary potential of individual genes, with meaningful implications for the evolvability of organisms and populations as well.
Our observations, when combined with those of others, indicate that the evolvability of proteins is generally and profoundly rooted in their genetic variation.
Examples from nature and the laboratory have shown that independent evolution trials from a single genotype often follow very similar genetic and evolutionary trajectories, suggesting that evolution is largely deterministic from a particular genetic starting point [35] [36] [37] [38] [39] [40] . On the other hand, the prevalence of epistasis causes distinct mutational effects amongst potential adaptive mutation(s) for otherwise phenotypically similar orthologs [14] [15] [16] [17] , suggesting that genetic variation epistatically "restricts" and/or "permits" the accessibility of certain adaptive mutations 12, 41, 42 . The successful evolution of new protein functions may therefore rely on genetic drift to explore the sequence space, and generate diverse genotypes with differently evolvable genotypes 16 . The genetic diversity that these neutral drifts generate thereby provide a foundation for the response of a population to new selection pressures 9, 41 . One complicating aspect of this model is the impact of temporal and spatial occurrences of selection pressure on the emergence of diverse genotypes. It is possible that this model explains a commonly observed phenomenon in bacterial adaptation, e.g., drug-resistance and xenobiotic degradation 43,44 , in which typically there are only a small number of genotypes in a larger population that emerge to confer new functions, after which point these successfully adapted genes quickly disseminate to other bacteria via horizontal gene transfer.
Our observations suggest that the conventional paradigm, where protein stability is the dominant factor in determining evolvability 23-25 , cannot account for variation in evolutionary potential between the MBL enzymes toward PMH activity. Instead, we found that cryptic and subtle molecular differences have a far greater impact on enzyme evolvability. Moreover, the initial fitness and phenotypes of the enzymes does not necessarily provide a good indicator for their eventual evolutionary outcomes. Thus, adaptive evolutionary potential can be truly "cryptic" and only apparent after evolution happens, and further it is extremely difficult to predict.
These results also have profound implications for protein design, engineering and laboratory evolution: protein engineers overwhelmingly choose a single starting genotype based on the availability of biochemical and structural information (often the highest initial activity), and much effort has been devoted to develop technologies to overcome evolutionary dead-ends 45-47 . Our observations suggest that it would be more effective to explore diverse genotypes and identify the most evolvable starting sequences to successfully obtain an optimized functional protein. The biophysical rationalization of the cryptic properties of MBL enzymes described here contribute to the ambitious goal of understanding the molecular mechanisms behind neutral genetic variation and evolvability that we observe in nature, in such a way as to allow us to predict evolutionary pathways and understand how to acquire better biological molecules. 
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Material and Methods

Generation of mutagenized library
Random mutant libraries were generated with error-prone PCR using nucleotide analogues (8- 
Oxo
Generation of DNA shuffling libraries
The staggered extension process (StEP) protocol was used to recombine equally improved mutants 48 . Plasmids of variants were mixed in equimolar amounts to 500 ng of total DNA and used as a template for the StEP reaction. Cycling conditions: Initial denaturation at 95°C for 5 minutes followed by 100 cycles 95°C for 30 s followed by 58°C for 5 s. PCR products were purified using the Cycle Pure PCR purification kit and further amplified with a 2 × Master mix of Econo TAQ DNA polymerase. Libraries were cloned into pET29(b) as described above.
Site-directed mutagenesis
Single-point mutant variants were constructed by site-directed mutagenesis as described in the QuikChange Site-Directed Mutagenesis manual (Agilent) using specific primers. All variants contained only the desired mutation, which was confirmed by DNA sequencing.
Pre-screen on agar plates
Libraries in pET29-pMBP were electroporated into E. coli BL21 (DE3) cells and incubated for 1 h at 37°C prior to plating. For the low antibiotic prescreen, the transformants were plated on agar 
Cell lysate activity screen in 96-well plates
To test the fitness and solubility of the variants, individual wells of a 96-well plate containing 400 µl of LB media supplemented with 40 µg/ml kanamycin were inoculated with 20 µl of overnight culture and incubated at 30°C for 3 hours. Protein expression was induced by adding IPTG to a final concentration of 1 mM and further incubation at 30°C (20°C and 37°C for testing temperature effect on expression) for 3 hours. Cells were harvested by centrifugation at 4,000 × g for 10 min and pellets were frozen -80°C for at least 30 min. For lysis, cell pellets were resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 200 µM ZnCl 2 , containing 0.1 % Triton X-100, 100 µg/ml lysozyme and 1 U/ml of benzonase) and incubated at 25°C with shaking at 1200 rpm for 1 hour. The cell lysates were clarified by centrifugation at 4,000 × g for 20 min at 4°C. Clarified lysates were diluted (1000-fold for β-lactamase activity 2-fold for phosphonate hydrolase activity) in order to obtain linear initial rates and measured against a single substrate concentration (90 µM for β-lactamase activity and 500 µM for phosphonate hydrolase activity).
Purification of Strep-tagged proteins
All variants were cloned as described above, transformed, overexpressed in E. coli BL21 (DE3) cells and purified as described previously 27 .
Enzyme kinetics
The kinetic parameters and activity levels of purified of enzyme variants were obtained as described previously 27 . Briefly, phosphonatase monoester hydrolase activity was monitored following the release of p-nitrophenol at 405 nm with an extinction coefficient of 18,300 M -1 cm -1 . The β-lactamase activity was monitored at 405 nm for the Centa substrate, and molar product formation was calculated with the extinction coefficient of 6,300 M -1 cm -1 .
Thermostability assay
The thermal stability of variants was measured with a thermal shift assay as described 
Protein purification for crystallization
The NDM1 and VIM2 protein variants were expressed in E. coli BL21 (DE3) cells in TB medium (400 ml) supplemented with 1% glycerol, 50 µg/ml kanamycin and 200 µM ZnCl 2 .
Cells were grown at 30 °C for 6 hours. The temperature was lowered to 22°C and the cells were 
Data collection and structure determination
The crystallographic data were collected at 100 K at the Australian Synchrotron. Data were processed using XDS 50 . Scaling was performed using Aimless in the CCP4 program suite.
Resolution estimation and data truncation were performed by using overall half-dataset correlation CC(1/2) > 0.5 51 . Molecular replacement was used to solve all structures with MOLREP 52 using the structures deposited under PDB accession codes 3SPU and 1KO3 as starting models for NDM1 and VIM2, respectively. The model was refined using phenix.refine 53 and Refmac v5.7 54 in CCP4 v6.3 program 55 , and the model was subsequently optimized by iterative model building with the program COOT v0.7 56 .
Molecular dynamics simulation
Molecular dynamics simulations VIM2 and NDM1 variants were performed using the Q simulation package 57 and the OPLS-AA force field 58 . OPLS-AA compatible parameters for pnitrophenyl phenylphosphonate (PMH substrate, PPP) were generated using MacroModel version 10.3 (Schrödinger LLC, v. 2014-1). Partial charges for PPP were calculated using the standard RESP procedure 59 , with the use of Antechamber (AmberTools 12) 60 and Gaussian09
(Revision C.01) 61 . All other PPP parameters were as presented in the supporting information of Ref. 62 . The structures of VIM2-WT (PDB ID 4PVO) and NDM1-WT (PDB ID 4HL2) were obtained from the Protein Data Bank, and the structure of NDM1-R10 with the PMH product bound (PDB ID 5K4M) was obtained as described in the previous section. The structures of single W93G mutants of both VIM2 and NDM1 were generated by manually mutating the respective tryptophan residues to glycine in the WT structures. In the simulations of VIM2 chain B of the PDB structure was used. The PMH substrate was placed manually in the active site of the respective enzymes based on the position of the PMH product found in the crystal structure of NDM1-R10. The Zn 2+ ions were described using a tetrahedral dummy model based on the dummy model originally described by Åqvist and Warshel 63 . The model was built by placing four dummy atoms in a tetrahedral geometry around a central metal particle, and parametrised to reproduce the experimental solvation free energy and solvation geometry of the zinc ion (for the description of analogous octahedral dummy model and parameterization procedure see Ref. 64 ).
The resulting Zn 2+ parameters used in this work are presented in Supplementary Table 9 . All simulations were performed using surface-constrained all-atom solvent (SCAAS) boundary conditions 65 applied to a spherical droplet of TIP3P water molecules 66 with a radius of 24 Å centered on the bridging hydroxide ion. All protein atoms and water molecules within 85% of the solvent sphere were allowed to move freely with no restraints, atoms in the last 15% of the sphere were subject to 10 kcal mol -1 Å -2 positional restraints, and all atoms outside this sphere were subjected to 200 kcal mol -1 Å -2 positional restraints to maintain them at their crystallographic positions. Protonation states of all ionisable residues within the inner 85% of the simulation sphere were assigned using PROPKA 3.1 67, 68 and the protonation states of histidine side chains were determined by visual inspection of the surrounding hydrogen bonding pattern of each residue. The relevant protonation states and histidine protonation parameters are presented
in Supplementary Table 10 . All ionizable residues outside of the 85% of the sphere were kept in their uncharged forms to avoid simulation artefacts caused by having charged residues in the excluded region of the simulations. All systems were initially equilibrated with 200 kcal mol -1 Å -2 positional restraints over the total timescale of 95 ps, during which the alternating heating, cooling and reheating was performed to release steric clashes and equilibrate the positions of the solvent molecules and hydrogen atoms, and to reach the target simulation temperature of 300K.
The initial equilibration was completed by performing 10 ns of simulation at 300K, which was followed by 100 ns production simulation, the last 50 ns of which was subject to further analysis.
This protocol was repeated five times generating five independent 100ns trajectories for each system. The root mean square deviations of all C-a atoms in our simulations is shown in The cell lysate was diluted by 2-fold, and the activity was measured with 500 µM for p-nitrophenyl-phenylphosphonate. The presented value indicates the activity level in the undiluted cell lysate. Supplementary Table 4 . Changes in catalytic activity of purified enzymes compared to its wild-type enzyme, and melting temperature of MBL mutants. Supplementary Table 10 . List of relevant ionized states as well as the protonation patterns of histidine residues in our molecular dynamics simulations. All other residues were kept in their unionized forms as they were outside the simulation sphere (see main text). 
Residue
